Sign in

CIK 0001521036

  • Large accelerated filer

Lantheus Holdings, Inc.

Sign in to watch
Ticker
LNTH
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
352318913
Phone
+1 978-671-8001
Business address
201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
Former names
Lantheus MI Holdings, Inc.
  1. 4 Open-market sale Director sold 5,000 shares at $21.17 ($105,840)
  2. 4 Open-market buy Director bought 1,000 shares at $18.60 ($18,600)
  3. 4 Open-market sale President & CEO sold 27,157 shares at $18.26 ($495,838)
  4. 4 Grant or award President & CEO acquired 162,338 shares (grant or award)
  5. 4 Open-market sale Chief Commercial Officer sold 4,061 shares at $18.40 ($74,722)
  6. 4 Open-market sale Chief Operations Officer sold 1,887 shares at $18.40 ($34,721)
  7. 4 Open-market sale SVP and General Counsel sold 6,769 shares at an average $18.97 ($128,379)
  8. 4 Open-market sale CFO and Treasurer sold 2,280 shares at $18.40 ($41,952)
  9. 4 Open-market sale Chief Medical Officer sold 4,027 shares at $18.40 ($74,097)
  10. 4 Open-market sale SVP and General Counsel sold 1,473 shares at $19.08 ($28,108)
  11. 4 Open-market sale Chief Operations Officer sold 1,187 shares at $19.08 ($22,650)
  12. 4 Open-market sale CFO and Treasurer sold 1,465 shares at $19.08 ($27,955)
  13. 4 Open-market buy Director bought 1,000 shares at $18.02 ($18,020)
  14. 4 Open-market buy Director bought 1,000 shares at $19.39 ($19,390)
  15. 4 Open-market buy Director bought 1,000 shares at $20.03 ($20,030)
  16. 5 Insider Annual Insider Trading Report
  17. 4 Open-market buy Director bought 1,000 shares at $17.94 ($17,940)
  18. 4 Open-market buy Director bought 1,000 shares at $16.13 ($16,130)
  19. 4 Open-market buy Director bought 1,000 shares at $15.29 ($15,290)
  20. 4 Open-market buy Director bought 1,000 shares at $15.80 ($15,800)

Page 16 of 30 · 599 filings